Centanafadine (Simtriyo): A New Medication for ADHD
From PsychRounds: The Psychiatry Podcast · · 28 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
Welcome back! Today, we are talking about Simtriyo, which has generated a lot of media attention recently given a newly minted FDA approval for ADHD.
References
https://pmc.ncbi.nlm.nih.gov/articles/PMC12314114/
https://pmc.ncbi.nlm.nih.gov/articles/PMC12379780/
https://pubmed.ncbi.nlm.nih.gov/31776871/
https://pubmed.ncbi.nlm.nih.gov/40619095/
Back to PsychRounds: The Psychiatry Podcast · Report a problem